Prognosis of AKI in malignant diseases with and without sepsis

BMC Anesthesiology

Table 1 Outcome characteristics

Variables	Survivors	Non-survivors	p-value
Age	64.3 ±16.6 years	69.5 ±13.5 years	<0.001
Male gender	440 (58%)	168 (64%)	0.066
SAPS II	30.4 ±10.7	41.8 ±10.9	<0.001
AKI	287 (37%)	148 (56%)	<0.001
Sepsis	175 (23%)	156 (60%)	<0.001
AKI+Sepsis	105 (16%)	117 (45%)	<0.001
Cancer	135 (17%)	76 (29%)	<0.001
Liver cirrhosis	52 (7%)	30 (12%)	0.017
Dialysis	224 (30%)	120 (46%)	<0.001
ICU stay	7.4 ±8.1 days	7.4 ±8.4 days	0.9
Controlled ventilation	244 (32%)	185 (71%)	<0.001

Table 1 compares frequencies of different variables / mortality risk factors between survivors and non-survivors. The differences between the two groups were significant in all analyzed categories, with the exception of male gender and length of ICU stay. Table 1 shows frequencies of the three AKIN stages in AKI patients if used for diagnosis, followed by the respective mean serum creatinine concentrations at the time of admission to the ICU (results as mean ±SEM).

ISSN: 1471-2253